An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.
Trending
- Kaylee Hottle, Star Of Godzilla Vs. Kong, Dies Aged 18
- ‘Antifa’ song climbs to top of charts after TV cancellation
- 'France wants to lead the way' with under-15s social media ban
- Car crashes – latest news updates
- Why checks are suddenly the summer print (and not an autumn trend)
- Georgian organisations claim state festivals are being hijacked by “authoritarian regime” | News
- Viktor&Rolf begeleidt modestudenten van Istituto Marangoni Paris
- June Squibb Joins ‘Turn The Lights Back On’ Opposite Alex Borstein
